Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81fb736bb33a8f5086e3d7a3c6dc65be |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aba7922d0d12ed71140c3a1151797d56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9bacf6f4bafc9dc8f09e402c58158fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3e68f4eacfce57ebab293e0f792d16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8389c4f921eabf2ed1517dcf7bd44f58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8704bdf1771316a49b52490136537c75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2add09af2113c5b32c7278ce96e777f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bd87c3595521b4904b7d9022e7378c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17a92efcd1489ebb0a80041e4c22959a |
publicationDate |
2021-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3634957-B1 |
titleOfInvention |
Nmda receptor modulators, compositions comprising same and use of these compounds in the treatment of diseases involving the central nervous system |
priorityDate |
2017-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |